Placebo + Primatene Mist + Epinephrine inhalation

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
72
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Asthma

Conditions

Asthma

Trial Timeline

Nov 1, 2011 โ†’ Jul 1, 2012

About Placebo + Primatene Mist + Epinephrine inhalation

Placebo + Primatene Mist + Epinephrine inhalation is a phase 3 stage product being developed by Amphastar Pharmaceuticals for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT01476904. Target conditions include Asthma.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT01476904Phase 3Completed